Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Inhibitex

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel antibody-based products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting. We currently have two product candidates in clinical development and four product candidates in preclinical development. Our product candidates have been developed based upon our expertise in MSCRAMM® proteins, for which we own or have licensed numerous patents and patent applications. MSCRAMM® proteins are located on the surface of pathogenic organisms, such as bacteria and fungi, and play a prominent role in the process of infection. These proteins enable organisms to initiate and maintain an infection by adhering to specific sites on human tissue or implanted medical devices. Our antibody-based product candidates are designed to bind to specific MSCRAMM® proteins, thereby reducing the incidence and severity of infections.
Our lead product candidate, Veronate®, is being developed for the prevention of hospital-associated infections in premature, very low birth weight (VLBW) infants. We have completed the enrollment phase of a 2,000 patent pivotal Phase III trial of Veronate®, and we anticipate data from this trial to be available in the second quarter of 2006. Veronate® has been granted both Fast Track and Orphan Drug status by the FDA and has been designated an orphan medicinal product by the EMEA in Europe. Our second product candidate, Aurexis®, is being evaluated in clinical trials as a first-line therapy, in combination with standard of care antibiotics, to treat serious Staphylococcus aureus (S. aureus) bloodstream infections in hospitalized patients.


Contact Details:
9005 Westside Parkway
Alpharetta
Georgia
30004
United States of America
Tel:678.746.1100
Fax:
Email:
WWW:

www.inhibitex.com/




Loading...

Recent Publications by Inhibitex:

Unique anthranilic acid chemistry facilitates profiling and characterization of Ser/Thr-linked sugar chains following hydrazinolysis.
A novel method for the analysis of Ser/Thr-linked sugar chains was made...
8th March, 2008
Analytical Biochemistry, Research and Development, Inhibitex, Alpharetta, Anal Biochem. 2008 Feb 1;373(1):104-11. Epub 2007 Sep 25.
DOI Direct Link
Automated sample preparation facilitated by PhyNexus MEA purification system for oligosaccharide mapping of glycoproteins.
A reproducible high-throughput sample cleanup method for fluorescent...
6th December, 2007
Analytical Chemistry, Inhibitex, Alpharetta, GA 30004, USA. Anal Biochem. 2007 Oct 15;369(2):202-9. Epub 2007 Jul 25.
DOI Direct Link
Monoclonal antibodies recognizing the Enterococcus faecalis collagen-binding MSCRAMM Ace: conditional expression and binding analysis.
Enterococci are opportunistic pathogens known to cause numerous clinical...
26th September, 2007
Inhibitex, Inc., 9005 Westside Parkway, Alpharetta, GA 30004, USA. Microb Pathog. 2007 Aug-Sep;43(2-3):55-66. Epub 2007 Apr 19.
DOI Direct Link
A panel of monoclonal antibodies recognizing the Staphylococcus epidermidis fibrinogen-binding MSCRAMM SdrG.
Staphylococcus epidermidis is an important opportunistic human pathogen...
22nd March, 2007
Inhibitex, Inc., Alpharetta, Georgia 30004, USA. Hybridoma (Larchmt). 2007 Feb;26(1):28-34.
DOI Direct Link
Advances in fluorescence derivatization methods for high-performance liquid chromatographic analysis of glycoprotein carbohydrates.
Nosocomial or hospital-acquired infections are associated with prolonged...
28th April, 2006
Analytical Biochemistry, Inhibitex Inc., Alpharetta, GA 30004, USA. Anal Biochem. 2006 Mar 1;350(1):1-23. Epub 2005 Oct 17.
DOI Direct Link

View more Inhibitex research publications.

Press Releases on Inhibitex:

BioPortfolio Logo
Georgia Showcases its Bioscience Leadership at 2008 Bio International Convention 4th June, 2008 Georgia Department of Economic Development
ATLANTA, June 4 /PRNewswire/ -- Georgia will showcase its bioscience leadership at the 2008 Bio international convention on June 17 -- 20, in San Diego, Calif. Governor Perdue will deliver

BioNews Results for Inhibitex:

Inhibitex to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
Pharma Live:  Nov 13 2009 4:41PM Matching: inhibitex
Inhibitex Reports Third Quarter 2009 Financial Results
Pharmacy Choice:  Nov 6 2009 7:02PM Matching: inhibitex
Inhibitex Reports Third Quarter 2009 Financial Results
SmartBrief:  Nov 6 2009 4:28PM Matching: inhibitex
Third quarter 2009 financial results announced by Inhibitex
News-Medical.Net:  Nov 6 2009 1:07PM Matching: inhibitex
Inhibitex Reports Third Quarter 2009 Financial Results
Genetic Engineering News:  Nov 6 2009 12:57PM Matching: inhibitex
Promote your company here: BioNewsCast - Press Release Distribution

View more Inhibitex news.

Inhibitex Patents:

US Patent No.Title
7381793 Extracellular matrix-binding proteins from Staphylococcus aureus
6692739 Staphylococcal immunotherapeutics via donor selection and donor stimulation
6703025 Multicomponent vaccines
6841154 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and Staphylococcus aureus
6979446 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections

View more Inhibitex patents.

Inhibitex (INHX) Financial information Links from Barchart

INHX Quote from from Barchart.com
INHX Chart from from Barchart.com
INHX Profile from from Barchart.com
INHX Opinion from from Barchart.com

View more Inhibitex finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 510 times since April 2007, the link to the organisation's website has been followed 70 times

Recent Search Terms used to find this page: Inhibitex location | inhibitex pharma | inhibitex alpharetta | inhibitex alpharetta | inhibitex pharma location | inhibitex pharma | inhibitex pharma | inhibitex pharma | inhibitex pharma | inhibitex pharma | .

Search for more companies in Alpharetta

Search for more companies in Georgia



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Inhibitex

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.